The trends in the pharmaceutical outsourcing space highlight the growing demand for external providers due to the increasing complexity of drug development, especially in areas like biologics and cell and gene therapies. The COVID-19 pandemic has further accelerated the reliance on external resources for drug discovery and development. Challenges, such as excess capacity and reduced biotech funding, have impacted CDMOs, but trust, transparency and high-quality service remain crucial for maintaining strong relationships with clients.
The report also delves into market drivers accelerating CDMO growth, including partnerships, bioprocessing excellence, research and development (R&D) laboratory infrastructure, sustainability, digitalization, supply chain resilience and regulatory compliance expertise. The analysis of mergers and acquisitions (M&A) trends in the CDMO space reveals a recent slowdown in transactions and values, but the overall 10-year trend indicates sustained interest and private capital inflow. PE transactions represent close to 80% of all M&A activity in the last three years, with a majority of cross-border deals.
From 2017 to early 2021, the biopharma CDMO index experienced substantial growth, surpassing the Standard and Poor’s (S&P) 500 due to increased demand and capacity shortages. However, from 2021 onwards, CDMO multiples fluctuated and decreased. Despite this, the mean EV / EBITDA and EV / Revenue multiples from January 2019 to August 2023 were 19.8X and 3.7X, respectively, still representing a 30-40% increase over the S&P 500 multiples during the same period.
Factors driving PE interest in CDMOs include product class differentiation, strategic portfolio growth, efficiency, digitization, development and manufacturing capabilities and global footprint and accreditation. The report also provides insights into how CDMOs can adopt branding and messaging strategies to position themselves as attractive PE targets.
In conclusion, despite recent challenges such as the “COVID-19 cliff,” CDMOs are well-positioned to contribute to the evolving pharmaceutical landscape. PE interest underscores the attractiveness of CDMOs as investment opportunities, and the report anticipates a positive outlook for the industry, aligning with the broader trends in pharmaceutical outsourcing.
The report is a collaborative effort between ramarketing and Lincoln International, highlighting their expertise in life science marketing and investment banking advisory, respectively.
Please complete the form below to request a copy of this report.
By submitting this request, you permit us to also share your contact information with ramarketing.
Contributors
Meet Professionals with Complementary Expertise in Healthcare
Related Perspectives
Recent Transactions in Healthcare
Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal
The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More about Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal
Packaging Quarterly Review Q4 2023
Mergers and acquisitions (M&A) markets closed Q4 2023 in a similar vein to previous quarters, with a decline in completed deals. The packaging market closely followed suit, also experiencing a… Read More about Packaging Quarterly Review Q4 2023
Supplements – A Bright Spot in the Pet Industry
As we embark on a new year, it’s an opportune time to reflect on the “bright spots” within the pet industry that present exciting prospects, particularly as the pet industry… Read More about Supplements – A Bright Spot in the Pet Industry
Beauty Independent | The Prognosis for Beauty M&A and Early-Stage Funding in 2024
Originally posted by Beauty Independent on January 22, 2024. Mergers and acquisitions (M&A) activity in the beauty market is on the up. “Looking forward, the recent deal announcements support the… Read More about Beauty Independent | The Prognosis for Beauty M&A and Early-Stage Funding in 2024
Lincoln International adds Lalit Kasat as Managing Director in London
Lincoln International, a global investment banking advisory firm, is pleased to announce that Lalit Kasat has joined as a Managing Director in the firm’s Technology, Media & Telecom (TMT) Group… Read More about Lincoln International adds Lalit Kasat as Managing Director in London
Lucas Naumann
Lucas provides mergers and acquisitions (M&A) advisory services to private equity firms and privately held businesses, with a focus on Software as a Service, human capital management and enterprise technology.… Read More about Lucas Naumann
Lalit Kasat
Lalit provides mergers and acquisitions advisory and growth equity fundraising services to private equity firms, founders and corporations in the technology industry, with a focus on business-to-business (B2B) software, data… Read More about Lalit Kasat
VentureCapital Magazin | Courageous Decisions Needed: Commentary on the 2024 German M&A Market
Originally posted by VentureCapital Magazin on January 5, 2024. Rising interest rates, increased energy costs, geopolitical conflicts and poor economic forecasts led to a slower German mergers and acquisitions (M&A)… Read More about VentureCapital Magazin | Courageous Decisions Needed: Commentary on the 2024 German M&A Market
Scrip Asks…What Does 2024 Hold for Biopharma?
James West, Managing Director in Lincoln’s Healthcare Group, recently discussed his expectations for the biopharma market in 2024 as part of Scrip’s series. Part One – Business Strategy and Leadership… Read More about Scrip Asks…What Does 2024 Hold for Biopharma?
Lisa Weigel
Lisa provides buy-side and sell-side mergers and acquisitions advisory services to private equity firms, small and medium-sized enterprises, entrepreneurs and multinational corporates in the industrials industry. Lisa harnesses her deep… Read More about Lisa Weigel
Lincoln International Announces Promotions to Drive Ongoing Organizational & Client Success
Lincoln International, a global investment banking advisory firm, today announced the appointment of several firm leaders into executive management and client advisory roles. The firm has promoted Mary Weber to… Read More about Lincoln International Announces Promotions to Drive Ongoing Organizational & Client Success
Vincent Smulders
Vincent provides mergers and acquisitions advisory services to private equity firms, corporates and entrepreneurs in the industrials and healthcare industries. Vincent works closely with his clients, guiding them through each… Read More about Vincent Smulders
2023 Global Results
Just Food | Cautious Optimism Oozes Around Food M&A Outlook in 2024 as Risks Fester
Originally posted by Just Food on December 14, 2023. While deal activity in the food industry has slowed, businesses that passed on pricing and kept their volumes from going backward… Read More about Just Food | Cautious Optimism Oozes Around Food M&A Outlook in 2024 as Risks Fester
Sustainability in Focus for Packaging M&A
The packaging industry faces a paradigm shift amidst a growing public conversation on climate change and, as a result, the concerted endeavors of governments worldwide to regulate single-use packaging and… Read More about Sustainability in Focus for Packaging M&A
Bloomberg TV | Lincoln International CEO Gives 2024 Outlook
Originally posted by Bloomberg on December 27, 2023. Rob Brown, CEO of Lincoln International, discusses his 2024 mergers and acquisitions market predictions, including an increasing focus from Western companies on… Read More about Bloomberg TV | Lincoln International CEO Gives 2024 Outlook
The Loadstar | When Consolidation Pressure Meets a Cautious Outlook: M&A in 2024
Originally posted by The Loadstar on December 12, 2023. In 2023, global growth was limited by escalating geopolitical conflicts and central bank actions to combat inflation and soaring energy costs,… Read More about The Loadstar | When Consolidation Pressure Meets a Cautious Outlook: M&A in 2024
Women’s Wear Daily | What to Expect from Beauty M&A in 2024
Originally posted by Women’s Wear Daily on December 8, 2023. Many expect beauty brands to come to market in 2024, but the exact timing will be contingent on several dynamics.… Read More about Women’s Wear Daily | What to Expect from Beauty M&A in 2024
Five Key Insights from Agritechnica Trade Fair – A Full House in Hanover
Record crowds in Germany and exhibit halls full of new products suggest the agricultural equipment industry has a bright future Lincoln International’s industrials team was well represented at this year’s… Read More about Five Key Insights from Agritechnica Trade Fair – A Full House in Hanover
Best Practices for Preparing a Corporate Carve Out
While macroeconomic challenges and rising interest rates correlate to a slowdown in mergers and acquisitions, corporate carve out transactions often see significant upticks during times of economic uncertainty as businesses… Read More about Best Practices for Preparing a Corporate Carve Out
Transport Topics | Mergers and Acquisitions Market Begins to Accelerate
Originally posted by Transport Topics on November 13, 2023. Mergers and acquisitions (M&A) activity is anticipated to rise, given the stabilization of economic challenges and the adaptation of industry players… Read More about Transport Topics | Mergers and Acquisitions Market Begins to Accelerate
Cybersecurity Report: Q3 2023
Q3 2023 cybersecurity M&A and investment deal volumes increased from the previous quarter for the first time in 2023, while cyber public share price performance improved as valuations and profit… Read More about Cybersecurity Report: Q3 2023
Recycled Plastics Market Draws Investor Attention
Not a day goes by without the announcement of a new regulatory, industrial, or commercial initiative relating to the European circular economy, making it a major topic for corporates and… Read More about Recycled Plastics Market Draws Investor Attention
Corporate Carve Outs: A Strategic Growth Tool for Turbulent Times
When challenges arise in the economic environment, businesses become much less interested in discretionary acquisitions—particularly larger deals or at higher multiples, creating a need for dealmaking alternatives. The result is… Read More about Corporate Carve Outs: A Strategic Growth Tool for Turbulent Times
In Japan, M&A Set To Climb Amidst Low Rates And Regulatory Changes
Japan is a country with advanced and independent sensibilities in terms of its traditions, aesthetics and, especially, how it does business – demonstrable in a 14 percent increase in mergers… Read More about In Japan, M&A Set To Climb Amidst Low Rates And Regulatory Changes